Alert detail
LCD L37857: MolDX: Envisia™, Veracyte™, Idiopathic Pulmonary Fibrosis Diagnostic Test — Palmetto GBA
What changed
Palmetto GBA covers Envisia™ IPF genomic test under MolDX criteria.
Who’s affected: Pulmonology billing teams · Effective: June 29, 2023
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 7 billing codes.
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.